Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Breast Cancer Clinical Trials and Research

  • New Patient Appointments

    Make Appointment Online
    Dana-Farber Brigham Cancer Center logo
    US News adult badge - smaller

  • Clinical Trials Questions?



  • Dana-Farber's Eric P. Winer, MD, Explains Results of HER2CLIMB Trial
    This trial looks at a new breast cancer drug called tucatinib, combined with standard therapies. Results presented at SABCS 2019.